⌘K

Login Start Free

Home/Filings/5/0000719135-21-000015

5//SEC Filing

Swandal Craig A. 5

Accession 0000719135-21-000015

CIK 0000719135other

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 12:36 PM ET

Size

10.4 KB

Accession

0000719135-21-000015

Insider Transaction Report

Form 5

Period: 2020-12-31

Apyx Medical CorpAPYX

Swandal Craig A.

Director

Transactions

Exercise/Conversion
Common Stock
2020-03-04$7.28/sh+9,916$72,188→ 17,000 total
Exercise/Conversion
Common Stock
2020-10-07$7.28/sh+7,084$51,572→ 17,000 total
Exercise/Conversion
Stock Option (Option to Buy)
2020-03-04$7.28/sh−9,916$72,188→ 0 total
Exercise: $7.28From: 2020-08-01Exp: 2029-08-01→ Common Stock (9,916 underlying)
Exercise/Conversion
Stock Option (Option to Buy)
2020-10-07$7.28/sh−7,084$51,572→ 0 total
Exercise: $7.28From: 2020-08-01Exp: 2029-08-01→ Common Stock (7,084 underlying)

Footnotes (1)

[F1]The transactions reported reflect the exercise of stock options.

Documents

1 file

5
wf-form5_161315136281956.xmlPrimary
FORM 5

Issuer

Apyx Medical Corp

CIK 0000719135

Entity typeother

Related Parties

1

filerCIK 0001736883

Filing Metadata

Form type: 5
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 12:36 PM ET
Size: 10.4 KB

View on SEC.gov